Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...

Age-related macular degeneration (AMD) is one of the leading causes of vision ... Since AMD is closely linked with aging, some researchers have turned their attention to metformin—a drug better known ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with <a target= ...

This growth in the Age-Related Macular Degeneration market is fueled by ... in research and development investments that lead to more drug approvals and improved reimbursement policies.

The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust ...